Study sheds light on how COVID-19 infection may lead to late pregnancy complications

GEMCOVAC-OM is an Omicron-specific mRNA-based booster vaccine. Credit: Shaun from Pixabay. The Drug Controller General of India (DCGI) has granted emergency use authorisation (EUA) for

An­thos Ther­a­peu­tics an­nounced Mon­day morn­ing that it is stop­ping a Phase II study of its next-gen­er­a­tion an­ti­co­ag­u­lant abelacimab in atri­al fib­ril­la­tion as a re­sult of